Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Moelis & Company (NYSE:MC - Free Report) by 322.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 98,000 shares of the asset manager's stock after buying an additional 74,800 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned about 0.13% of Moelis & Company worth $6,714,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. bought a new position in shares of Moelis & Company in the third quarter worth approximately $49,017,000. Natixis Advisors LLC grew its holdings in Moelis & Company by 179.2% in the 2nd quarter. Natixis Advisors LLC now owns 708,140 shares of the asset manager's stock worth $40,265,000 after acquiring an additional 454,478 shares during the last quarter. Hsbc Holdings PLC increased its position in shares of Moelis & Company by 40.7% in the second quarter. Hsbc Holdings PLC now owns 246,655 shares of the asset manager's stock valued at $14,113,000 after acquiring an additional 71,372 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Moelis & Company by 27.0% during the second quarter. Envestnet Asset Management Inc. now owns 293,529 shares of the asset manager's stock valued at $16,690,000 after acquiring an additional 62,444 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Moelis & Company during the third quarter worth about $3,433,000. 91.53% of the stock is currently owned by hedge funds and other institutional investors.
Moelis & Company Price Performance
Moelis & Company stock traded up $1.13 during mid-day trading on Friday, reaching $76.98. The stock had a trading volume of 326,264 shares, compared to its average volume of 631,628. Moelis & Company has a one year low of $46.24 and a one year high of $81.60. The company has a 50-day moving average price of $71.18 and a two-hundred day moving average price of $64.42. The company has a market capitalization of $5.77 billion, a price-to-earnings ratio of 145.25 and a beta of 1.33.
Moelis & Company (NYSE:MC - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The asset manager reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.02. The firm had revenue of $273.76 million for the quarter, compared to the consensus estimate of $273.58 million. Moelis & Company had a net margin of 4.22% and a return on equity of 12.15%. The business's revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.15) earnings per share. On average, equities research analysts anticipate that Moelis & Company will post 0.96 earnings per share for the current fiscal year.
Moelis & Company Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Monday, November 4th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 3.12%. The ex-dividend date of this dividend is Monday, November 4th. Moelis & Company's payout ratio is 452.83%.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on MC. Morgan Stanley reduced their price target on Moelis & Company from $67.00 to $66.00 and set an "underweight" rating on the stock in a report on Thursday, October 24th. Wells Fargo & Company began coverage on Moelis & Company in a report on Thursday, September 12th. They set an "equal weight" rating and a $70.00 target price for the company. Finally, UBS Group raised their price objective on shares of Moelis & Company from $54.00 to $60.00 and gave the stock a "sell" rating in a report on Tuesday, October 8th. Two analysts have rated the stock with a sell rating and six have given a hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $60.83.
Check Out Our Latest Stock Analysis on Moelis & Company
Moelis & Company Company Profile
(
Free Report)
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.
Featured Articles
Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.